Valuation Guizhou Yibai Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shanghai S.E. 11/11/2026			5-day change	1st Jan Change
3.200 ^CNY	+0.31%		-0.93%	-19.60%

10-30	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
08-20	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	4,134	6,438	4,379	4,506	2,801	3,122
Change	-	55.75%	-31.98%	2.89%	-37.83%	11.44%
Enterprise Value (EV) ¹	4,599	6,971	4,874	4,807	3,212	3,339
Change	-	51.58%	-30.08%	-1.38%	-33.17%	3.95%
P/E	18.1x	26.4x	-10.3x	43.4x	-8.86x	-9.48x
PBR	1.23x	1.84x	1.44x	1.47x	1.12x	1.43x
PEG	-	4.02x	0x	-0x	0x	-2.12x
Capitalization / Revenue	1.21x	1.92x	1.6x	1.6x	1.29x	1.68x
EV / Revenue	1.35x	2.08x	1.78x	1.7x	1.48x	1.79x
EV / EBITDA	7.57x	12x	12.3x	13.2x	-42.8x	219x
EV / EBIT	9.85x	16.1x	21.8x	28x	-12.4x	-22.5x
EV / FCF	59.2x	24.1x	-39.3x	28.7x	35.7x	12.2x
FCF Yield	1.69%	4.14%	-2.54%	3.49%	2.8%	8.23%
Dividend per Share ²	0.43	-	-	0.066	-	-
Rate of return	8.24%	-	-	1.16%	-	-
EPS ²	0.289	0.308	-0.539	0.131	-0.402	-0.42
Distribution rate	149%	-	-	50.4%	-	-
Net sales ¹	3,413	3,347	2,735	2,821	2,174	1,863
EBITDA ¹	607.6	580.7	395.1	363.4	-75.06	15.24
EBIT ¹	466.7	433.1	223.1	171.8	-259	-148.7
Net income ¹	228.8	243.8	-426.5	103.4	-317.2	-329.6
Net Debt ¹	465	532.5	494.6	300.7	410.9	217.1
Reference price ²	5.220	8.130	5.530	5.690	3.560	3.980
Nbr of stocks (in thousands)	791,927	791,927	791,927	791,927	786,890	784,394
Announcement Date	22/04/21	22/04/22	27/04/23	18/04/24	25/04/25	22/04/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GUIZHOU YIBAI PHARMACEUTICAL CO., LTD.	-	-	-	-	376M
ELI LILLY AND COMPANY	42.06x	14.21x	30.18x	0.47%	1,280B
JOHNSON & JOHNSON	41.04x	6.89x	19.37x	1.9%	675B
ABBVIE INC.	37.61x	8.63x	17.8x	2.34%	521B
ROCHE HOLDING AG	21.6x	5.24x	13.13x	2.49%	386B
MERCK & CO., INC.	104.47x	5.96x	25.4x	2.31%	363B
NOVARTIS AG	23.92x	5.8x	14.13x	2.74%	301B
ASTRAZENECA PLC	24.1x	4.84x	13.6x	1.8%	286B
AMGEN INC.	24.17x	7.41x	13.62x	2.16%	253B
GILEAD SCIENCES, INC.	-39.88x	7.38x	46.48x	1.95%	211B
Average	31.01x	7.37x	21.52x	2.02%	428B
Weighted average by Cap.	37.23x	8.91x	22.60x	1.69%